Offices of General Counsel

Intellectual Property Universal and Master Agreements

Body

Universal and Master Agreements

These agreements are available as starting points for negotiations with particular research sponsors for clinical and, in some cases, preclinical or other types of studies. Faculty members are welcomed to use these documents as starting points; however, all contracts must be processed through the appropriate office at each UT institution.

AbbVie Inc. - Master Clinical Study Agreement - Sponsor Initiated - Includes StemCentrx as an Affiliate - Effective 10/20/2016 for 5-year term (does not include Pharmacyclics - see Master CTA for Pharmacyclics [OGC#165622])

Abbott Laboratories - Diagnostic

Abbott Laboratories - Pharmaceuticals - Sponsored Clinical Study Agreement -   5/9/1994

Abbott Laboratories – Amended and Restated Master Clinical Study Agreement – Abbott Initiated – 3/26/2012

Abbott Laboratories - Master Clinical Study Agreement - Abbott Initiated - 12/7/2006

Adria - Research Agreement

Amgen, Inc. - Master Clinical Study Agreement for Phase I, II and III Studies Only - 12/27/2000 (UTMDACC, UTHSCHOU, UTMB, UTSMCDAL, UTHSCTY, UTHSCSA)

Amgen Master Materials and Funding Agreement - 6/8/2007

Army Research Laboratory (ARL) - Master Cooperative Research and Development Agreement (CRADA) – 5/30/2014

Astellas Pharma US, Inc. - Master Clinical Study Agreement - 4/18/2007

Astellas Pharma Global Development, Inc. – Amended and Restated Master Clinical Study Agreement – April 18, 2014

AstraZeneca Pharmaceuticals LP (AZPLP) - Clinical Trial Agreement (Sponsor Initiated, Effective February 1, 2006) 

  • Note:  Please see Letter Agreement between University of Texas System and AstraZeneca, dated 2/14/2006.

AstraZeneca LP/AstraZeneca Pharmaceuticals LP - Master Clinical Study Agreement (Sponsor-Initiated, Effective 3/16/2015)

AstraZeneca Pharmaceuticals LP & Medimmune Master Mutual CDA  (Effective 2/27/2017)

Biogen - Material Transfer Agreement - 6/24/1994

BoehringerIngelheim Pharmaceuticals, Inc. - Clinical Research Agreement - 7/13/1995

BoehringerIngelheim Pharmaceuticals, Inc. - Master Clinical Trial Agreement - Sponsor Initiated - (Effective 1/25/2012 - 1/25/2021)

BoehringerIngelheim Pharmaceuticals, Inc. (BIPI) - Master Confidential Disclosure Agreement (Effective 11/1/2016 for 5-Year Term [OGC#167258])

Bristol-Myers Squibb - Master Clinical Trial Agreement - 6/23/1998 (including Amendments #1, #2 and #3)

  • Amendment #1 effective 5/21/1999
  • Amendment #2 effective 7/2000
  • Amendment #3 effective 5/18/2001

California Biotechnology - Sponsored Research Agreement

Eli Lilly - Master Clinical Trial Agreement - 1/10/1995

  • Amendment #1 Effective 7/21/1998
  • Amendment #2 effective 12/14/1999
  • Amendment #3 effective 3/25/2002
  • Amendment #4 effective 12/12/2003
  • Amendment #5 effective 11/18/2004

Forest Research Institute - Amended and Restated Research Agreement - (Effective 1/1/2011 - 12/31/2017)

Fujisawa - Research and Study Agreement

Genentech - Clinical Research Agreement

Genentech (and Roche Affiliates) - Sponsor-Initiated Clinical Research Agreement - (Effective 1/16/2015 - 1/16/2025)

Genzyme - Master Clinical Study Agreement - 4/6/2010

GlaxoSmithKline (GSK) - Master Clinical Study Agreement - 11/10/2003

GlaxoSmithKline (GSK) - Restated and Amended Master Clinical Study Agreement - 11/24/2014

Hoffmann-La Roche - Master Clinical Research Agreement - 5/1/1996

Hoffmann-La Roche - Master Clinical Trial Agreement - 3/16/2009

Hoffmann-La Roche - Preclinical Lab Study Grant Agreement - Sponsor IND - 8/30/1994

Hoffmann-LaRoche - Preclinical Lab Study Grant Agreement - Funded Institutional IND- 2/14/1996

ICI Americas/Zeneca Pharmaceuticals - See Zeneca Pharmaceuticals

Integrated Therapeutics Group, Inc. - Clinical Trial Research Agreement - 8/2004

InterMune, Inc. - Clinical Study Agreement - 1/2005

Janssen Pharmaceutica Inc. - Clinical Study Agreement - 4/1995

Marion Merrell Dow - Non-Governmental Clinical Study Agreement - 2/2/1994

Matrix - Clinical Research Agreement

Medimmune & AstraZeneca Pharmaceuticals LP Master -  Master Mutual CDA - 2/27/2017

Merck & Co. - Clinical Study Agreement - 6/15/1995

NeoPharm, Inc. - Master Clinical Trial Agreement for Sponsor-Initiated Studies Only - 12/2002

Novartis Pharmaceuticals Corporation - Master Clinical Trial Agreement – Sponsor-Initiated

  • Effective 9/1/1998 through 8/31/2003
  • Amendment #1 (extends term: Effective 9/1/2003 through 12/31/2003)

Novartis Pharmaceuticals Corporation - Master Clinical Trial Agreement – Sponsor-Initiated

Novartis Pharmaceuticals Corporation - Master Clinical Trial Agreement – Sponsor-Initiated

Novartis Pharmaceuticals Corporation - Master Clinical Trial Agreement - Investigator-Initiated

  • Effective 11/12/2014 through 11/12/2019

Organon Incorporated - Clinical Trial Agreement - 6/14/1995

Pfizer - Amended and Restated Master Clinical Study Agreement (Sponsor Initiated) - 12/1/2015

Pfizer - Master Investigator-Initiated Research Grant Agreement - 12/1/2015

Pfizer - Master Program and Gift Agreement - 2/25/2008

Pfizer - Connecticut - Statement of Agreement - Clinical Study

Pfizer - New York - Clinical Study Agreement - Pfizer Initiated Study - 6/12/2003

Pfizer - New York - Clinical Study Agreement - 1/5/1995

Schering Plough Research Institute - Investigator Initiated Master Clinical Trial Research Agreement - 7/1/2004

Schering-Plough Research Institute - Master Clinical Trial Agreement - 6/15/2009

Statewide Clinical Trials Network (CTNeT) – Master Clinical Trial Agreement – 8/15/2012

Statewide Master Institutional Review Boards (IRB) Reciprocity Agreement - Signed by all UT System Institutions plus Angelo State University, Baylor College of Medicine, Rice University, Texas A&M University, Texas Tech University, Texas Tech University Health Sciences Center, Texas Tech University Health Sciences Center El Paso, The Methodist Hospital System, University of Houston, and University of North Texas Health Science Center - 4/19/2016 (effective through 6/30/2020)

UCB Biosciences - Master Clinical Trial Agreement - 8/13/2013

U. S. Department of Veterans Affairs - Interinstitutional Cooperative Technology Administrative Agreement -  2/14/2002

University Hospital Consortium - Clinical Trial Research Agreement -  4/21/1993

Upjohn - Non-Governmental Clinical Study Agreement -  10/5/1993

Warner-Lambert Company - Non-Governmental Clinical Trial Agreement - 8/1998

Wyeth Pharmaceuticals, Inc. - Master Clinical Study Agreement -   7/22/2003

Xoma - Clinical Research Agreement

 

Most of the master contracts specific to a particular UT institution are not available online. Contact BethLynn Maxwell in OGC for copies of standard contracts specific to UT institutions.

 

 

 

Disclaimer: The materials on this website do not constitute legal advice. You should consult with an attorney before acting on or conveying any interpretation of these materials.